EPA/DHA (Omega 3) Ingredients Market Size By Source (Anchovy/Sardine Oil, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oil, Tuna Oil, Cod Liver Oil, Salmon Oil, Krill Oil, Menhaden Oil), By Application (Dietary supplements, Pharmaceuticals, Functional Foods, Pet & Animal Feed, Infant Formulas), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2026

Published Date: Oct 2019  |  Report ID: GMI118  |  Authors: Kunal Ahuja, Kritika Mamtani

Report Format: PDF   |   Pages: 220   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Efficient consumption of supplements & functional foods rich in Omega-3 fatty acids to promote EPA DHA consumption

EPA/DHA (Omega 3) Ingredients Market size exceeded USD 2.6 billion, globally in 2018 and is estimated to grow at over 10.1% CAGR between 2019 and 2026.
 

EPA/DHA (Omega 3) Ingredients Market

Get more details on this report - Request Free Sample PDF
 

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are Omgea-3 fatty acids long chains, generally found in fatty layers of shellfish, cold water fish, fortified foods, algae oils and plant & nut oils. Foods rich in Omega 3 fatty acids includes trout, salmon, sardines, catfish halibut, shrimps, tuna, cod, flaxseed oil, herring, canola oils, spinach and walnuts. These products provide calories and gives energy for performing various body functions in lungs, heart, blood vessels and endocrine system.
 

Fatty acids are required for normal functioning of cells, nerves, organs and muscles. These are further utilized for production of hormone like compounds which maintains blood clotting, heart rate and blood pressure. Consumption of fish and other seafood products minimizes the risks of several chronic diseases such as cardiovascular, cancer, Alzheimer’s, rheumatoid arthritis (RA) and dementia.
 

Fish oil supplements are consumed for preventing heart diseases, ease inflammation, strengthening life and promoting mental health. Consumers in the U.S. are spending over USD 1 billion annually on over the counter fish oil products. Additionally, food companies are launching products such as yoghurt, milk, juice, cereals, chocolates and cookies with fish oil to enhance the flavor along with promoting the utilization of essential fatty acids.
 

Global dietary supplements market size was valued at over USD 115 billion in 2018. The growth has been attributed towards rising healthcare concerns, rising burden of lifestyle diseases and rapid increase in healthcare costs. Omega 3 fatty acids are majorly available as over the counter supplements which help minimize high triglyceride levels along with promoting overall heart health.
 

The American Heart Association recommends 1000 mg of combined EPA and DHA per day for people with coronary heart diseases. An average of 200 to 500 mg of both these products are recommended by various health organizations for healthy adults to maintain overall health. Also, FDA advises pregnant & breastfeeding women to include 8 to 12 ounces per week of low mercury fish to promote fetal growth and development.
 

EPA/DHA (Omega 3) Ingredients Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 2.6 Billion (USD)
Historical Data for: 2015 to 2018 Forecast Period: 2019 to 2026
Forecast Period 2019 to 2026 CAGR: 10.1% 2026 Value Projection: 5.7 Billion (USD)
Pages: 220 Tables, Charts & Figures: 265
Geographies covered (28): U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Norway, Denmark, Turkey, Ireland, China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Thailand, Vietnam, Brazil, Argentina, Chile, Ecuador, Saudi Arabia, South Africa, UAE
Segments covered: Application, Source and Region
Companies covered (9): BASF SE, DSM, Clover Corporation, Croda, Inc., Omega Protein, Nordic Naturals, COPEINICA ASA, EPAX AS, Arista Industries
Growth Drivers:
  • Asia Pacific: Dietary supplements industry growth
  • Europe: Supporting regulations regarding nutritional claims of omega-3 in food products
  • Increasing consumer adoption
  • Rising importance of omega 3 ingredients in pet and animal feed
Pitfalls & Challenges:
  • Restrictions on fish catches affecting fish oil production
  • North America: Stringent regulation regarding nutritional claims of omega 3 in food products

Request 15% Free Customization on this Report
 

Anchovy/sardine oils to remain a dominant source in EPA DHA production

EPA/DHA (Omega 3) Ingredients Market, By Anchovy/sardine oil, 2015 to 2026, (USD Million)
EPA/DHA (Omega 3) Ingredients Market, By Anchovy/sardine oil, 2015 to 2026, (USD Million)

Get more details on this report - Request Free Sample PDF
 

Based on source, the EPA/DHA (Omega 3) ingredients market is segmented into anchovy/sardine oils, high concentrates, medium concentrates, low concentrates, algae, tuna, salmon, krill and menhaden oils. Sardine oils are derived from tissue of sardine fish species containing a high percentage of long chain omega fatty acids EPA and DHA, essential for both animals and humans. The fish oil extracted from sardines and anchovies contains approximately 18% EPA and 12% DHA which are used in dietary supplements for curing cardiovascular diseases.
 

Anchovies and sardines have highest content of EPA and DHA, which can go above 90% and provide concentrators with the highest yields. Also, these oils play an important role in improving brain functions, memory problems including Alzheimer’s diseases and other cognitive deficiencies. 
 

Rapid adoption of fish oils in pharmaceutical formulations to promote Omega 3 Ingredients demand

EPA/DHA (Omega 3) Ingredients Market, By Pharmaceutical Application, 2018 & 2026, (USD Million)
EPA/DHA (Omega 3) Ingredients Market, By Pharmaceutical Application, 2018 & 2026, (USD Million)

Get more details on this report - Request Free Sample PDF
 

On the basis of application, the EPA DHA market is segmented into dietary supplements, functional food, pharmaceuticals, infant formula and pet & animal feed. Pharmaceutical grade is considered as the purest form of fish oils consisting of high amounts of essential fatty acids thereby assuring greater purity and safety. In the pharmaceutical grade, the Omega-3 content of fish oil should be approximately 1,000 mg per capsule with 200 mg DHA and 300 mg DHA.
 

Omega 3 is used as active pharmaceutical ingredient (API) in manufacturing medicines to prevent arthritis, heart disease and strokes. Various pharmaceutical manufacturers are actively involved in developing technologies to increase the concentration of Omega 3 ingredients in medicines. Certain fish oils such as cod liver and salmon oils are utilized as prescription medicines to minimize triglycerides levels.
 

Potential risks of chronic diseases in Asia Pacific to escalate demand for dietary supplements

China EPA/DHA (Omega 3) Ingredients Market, By Dietary Supplements, 2015 to 2026, (USD Million)
China EPA/DHA (Omega 3) Ingredients Market, By Dietary Supplements, 2015 to 2026, (USD Million)

Get more details on this report - Request Free Sample PDF
 

Asia Pacific region is dominated by non-communicable diseases (NCD) which are majorly driven by ageing population and unhealthy lifestyle choices. These diseases are responsible for more than 70% of the overall deaths according to WHO. As the life expectancy in the region is rising, the risks of non-communicable diseases such as mental illness, cancer, diabetes, osteoporosis and autoimmune diseases is rapidly growing. Rising incomes and shifting jobs from agriculture to manufacturing & services are expected to affect people’s lifestyles thereby enabling movement to cities.
 

Consumption of Omega 3 supplements is associated with lower risks of heart attacks, cancer, mental illness, Alzheimer’s and other cardiovascular diseases (CVD’s). Cod liver oils are used as dietary supplement and is the major source of vitamin A, D and essential Omega-3 fatty acids. As public health agencies are majorly promoting the reduction of risks related to chronic diseases, the demand for supplements in rising to prevent harmful medical conditions. China, India, japan and South Korea are the major markets for dietary supplements in Asia Pacific.
 

Joint ventures/ collaborations & product launches remain key growth strategy

In January 2018, DSM and Evonik established a new company Veramaris V.O.F. for the production of Omega 3 fatty acids EPA and DHA. These fatty acids are derived from natural marine algae for animal nutrition. It is a 50:50 joint venture, headquartered in Delft, Netherlands at the DSM Biotech Campus.
 

In January 2015, Croda, Inc. launched omega 3 emulsion range in convenient sachets or syrup applications with various flavors including lemon, blueberry peach & mango, and lemon flavors mainly for children and infant nutrition.
 

Various industry players are involved in partnerships & joint ventures to augment their global presence and enhance product portfolio. Global EPA DHA market consists of players including DSM, BASF, Croda Inc., PRONOVA, Arista Industries, EPAX, Omega Protein and NU MEGA INDUSTRIES.
 

The EPA/DHA Omega 3 Ingredients market research report includes in-depth coverage of the industry, with estimates & forecast in terms of volume in Tons revenue in USD from 2014 to 2025, for the following segments:

By Source:

  • Anchovy/sardine oils
  • High concentrate
  • Medium concentrate
  • Low concentrate
  • Algae oil
  • Cod liver oil
  • Salmon oil
  • Krill oil
  • Menhaden Oil

By Application

  • Dietary supplements
  • Functional foods
  • Pharmaceuticals
  • Infant formula
  • Pet & animal feed
  • Others

The above information has been provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Norway
    • Denmark
    • Turkey
    • Ireland
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Australia
    • Thailand
    • Indonesia
    • Vietnam
  • Latin America (LATAM)
    • Brazil
    • Argentina
    • Chile
    • Peru
    • Ecuador
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE

Frequently Asked Questions (FAQ) :

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are Omgea-3 fatty acids long chains, generally found in fatty layers of shellfish, cold water fish, fortified foods, algae oils and plant & nut oils.
Global market for EPA/DHA (omega 3) ingredients will achieve over 10% CAGR from 2019 to 2026.
Increasing demand for dietary supplements and rising consumer spending on health products will be key driving factors for the growth of global EPA/DHA (omega 3) ingredients business.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X